您当前的位置:
首页 >
文章列表页 >
Guideline for Monitoring and Management of Cardiovascular Toxicities Related to Lung Cancer Treatment
更新时间:2026-06-12
    • Guideline for Monitoring and Management of Cardiovascular Toxicities Related to Lung Cancer Treatment

    • China Oncology   (2026)
    • Received:11 June 2026

    移动端阅览

  • Guideline for Monitoring and Management of Cardiovascular Toxicities Related to Lung Cancer Treatment[J/OL]. China Oncology, 2026. DOI:

  •  
  •  

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Important progress in the surgical treatment of lung cancer in 2025
Important progress in surgical treatment of lung cancer in 2023
Research progress on H-E stained whole slide image analysis by artificial intelligence in lung cancer
Research progress on thyroid dysfunction induced by immunotherapy for lung cancer
Advances in fatty acid metabolism reprogramming of lung cancer

Related Author

CAO Hang
ZHANG Yang
CHEN Haiquan
Bin QIAN
Haiquan CHEN
Mengqi JIANG
Yuchen HAN
Xiaolong FU

Related Institution

Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center
Department of Thoracic Surgery, Jiangdu People’s Hospital of Yangzhou City
Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University
Institute of Thoracic Oncology, Fudan University
Department of Pathology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine
0